Welcome to our dedicated page for DXPRB news (Ticker: DXPRB), a resource for investors and traders seeking the latest updates and insights on DXPRB stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect DXPRB's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of DXPRB's position in the market.
Dynex Capital (NYSE: DX) has announced the tax treatment of its dividends declared in 2020. All dividends on common and preferred stocks were treated as capital gains, with no portion classified as ordinary income or return of capital. Key dividend payments include:
- Common Stock: Total of $1.66 per share across multiple payment dates.
- Series A Preferred Stock: $0.8795100 upon redemption.
- Series B Preferred Stock: $1.90625000, partly redeemed.
- Series C Preferred Stock: $1.12150000, first-quarter partial dividend.
Dynex Capital, Inc. (NYSE: DX) announced plans to redeem approximately 2.8 million shares of its Series B Cumulative Redeemable Preferred Stock (DXPRB) on February 15, 2021. Each share will be redeemed at $25, plus $0.1535590 in unpaid dividends, totaling $25.1535590 per share. On the redemption date, dividend accumulation for the Series B shares will cease. Shareholders must surrender their shares to receive the redemption amount. This announcement does not constitute a securities offer. Investors are advised to refer to the Company's Annual Report for further risks.
